Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 26

1.

Flammer syndrome.

Konieczka K, Ritch R, Traverso CE, Kim DM, Kook MS, Gallino A, Golubnitschaja O, Erb C, Reitsamer HA, Kida T, Kurysheva N, Yao K.

EPMA J. 2014 Jul 8;5(1):11. doi: 10.1186/1878-5085-5-11. eCollection 2014. Review.

PMID:
25075228
[PubMed]
Free PMC Article
2.

Towards personal health care with model-guided medicine: long-term PPPM-related strategies and realisation opportunities within 'Horizon 2020'.

Lemke HU, Golubnitschaja O.

EPMA J. 2014 May 30;5(1):8. doi: 10.1186/1878-5085-5-8. eCollection 2014.

PMID:
24883142
[PubMed]
Free PMC Article
3.

Predictive, Preventive and Personalised Medicine as the hardcore of 'Horizon 2020': EPMA position paper.

Golubnitschaja O, Kinkorova J, Costigliola V.

EPMA J. 2014 Apr 7;5(1):6. doi: 10.1186/1878-5085-5-6.

PMID:
24708704
[PubMed]
Free PMC Article
4.

'Suspect molecular signature' in blood as the indicator of undiagnosed breast cancer, cancer risk and targeted prevention.

Debald M, Yeghiazaryan K, Cebioglu M, Kuhn W, Schild HH, Golubnitschaja O.

EPMA J. 2013 Sep 16;4(1):22. doi: 10.1186/1878-5085-4-22.

PMID:
24228816
[PubMed]
Free PMC Article
5.

Position paper of the EPMA and EFLM: a global vision of the consolidated promotion of an integrative medical approach to advance health care.

Golubnitschaja O, Watson ID, Topic E, Sandberg S, Ferrari M, Costigliola V.

EPMA J. 2013 May 10;4(1):12. doi: 10.1186/1878-5085-4-12.

PMID:
23663422
[PubMed]
Free PMC Article
6.

The EPMA Journal introduces a new type of research article dedicated to predictive, preventive and personalised medicine.

Golubnitschaja O.

EPMA J. 2013 Mar 28;4(1):11. doi: 10.1186/1878-5085-4-11. No abstract available.

PMID:
23537054
[PubMed]
Free PMC Article
7.

Risk assessment, disease prevention and personalised treatments in breast cancer: is clinically qualified integrative approach in the horizon?

Golubnitschaja O, Yeghiazaryan K, Costigliola V, Trog D, Braun M, Debald M, Kuhn W, Schild HH.

EPMA J. 2013 Feb 19;4(1):6. doi: 10.1186/1878-5085-4-6.

PMID:
23418957
[PubMed]
Free PMC Article
8.

European strategies in predictive, preventive and personalised medicine: highlights of the EPMA World Congress 2011.

Golubnitschaja O, Costigliola V.

EPMA J. 2011 Dec;2(4):315-32. doi: 10.1007/s13167-011-0134-6. Epub 2011 Dec 29.

PMID:
23199170
[PubMed]
Free PMC Article
11.

Chromium-picolinate therapy in diabetes care: individual outcomes require new guidelines and navigation by predictive diagnostics.

Yeghiazaryan K, Schild HH, Golubnitschaja O.

Infect Disord Drug Targets. 2012 Oct;12(5):332-9.

PMID:
23017160
[PubMed - indexed for MEDLINE]
Free PMC Article
12.
13.

Promoting predictive, preventive and personalised medicine in global scale: the EPMA World Congress 2011.

Golubnitschaja O, Costigliola V.

EPMA J. 2011 Sep;2(Suppl 1):1-3. doi: 10.1007/s13167-011-0106-x. Epub 2011 Aug 24. No abstract available.

PMID:
23199182
[PubMed]
Free PMC Article
14.

Birth asphyxia as the major complication in newborns: moving towards improved individual outcomes by prediction, targeted prevention and tailored medical care.

Golubnitschaja O, Yeghiazaryan K, Cebioglu M, Morelli M, Herrera-Marschitz M.

EPMA J. 2011 Jun;2(2):197-210. doi: 10.1007/s13167-011-0087-9. Epub 2011 Jun 9.

PMID:
23199149
[PubMed]
Free PMC Article
15.

Promoting predictive, preventive and personalised medicine: European event of global importance.

Golubnitschaja O, Swanton C, Danesi R, Costigliola V.

EPMA J. 2011 Jun;2(2):131-6. doi: 10.1007/s13167-011-0088-8. Epub 2011 Jun 28. No abstract available.

PMID:
23199141
[PubMed]
Free PMC Article
16.

Chromium-picolinate therapy in diabetes care: molecular and subcellular profiling revealed a necessity for individual outcome prediction, personalised treatment algorithms and new guidelines.

Yeghiazaryan K, Peeva V, Shenoy A, Schild HH, Golubnitschaja O.

Infect Disord Drug Targets. 2011 Apr;11(2):188-95.

PMID:
21470100
[PubMed - indexed for MEDLINE]
Free PMC Article
17.

Degenerative valve disease and bioprostheses: risk assessment, predictive diagnosis, personalised treatments.

Yeghiazaryan K, Skowasch D, Bauriedel G, Schild HH, Golubnitschaja O.

EPMA J. 2011 Mar;2(1):91-105. doi: 10.1007/s13167-011-0072-3. Epub 2011 Apr 3.

PMID:
23199131
[PubMed]
Free PMC Article
18.

Editorial Letter: Promoting Predictive, Preventive and Personalised Medicine in global scale.

Golubnitschaja O.

EPMA J. 2010 Dec;1(4):523-4. doi: 10.1007/s13167-010-0052-z. Epub 2010 Nov 10. No abstract available.

PMID:
23199105
[PubMed]
Free PMC Article
19.

Predictive molecular profiling in blood of healthy vasospastic individuals: clue to targeted prevention as personalised medicine to effective costs.

Yeghiazaryan K, Flammer J, Golubnitschaja O.

EPMA J. 2010 Jun;1(2):263-72. doi: 10.1007/s13167-010-0032-3. Epub 2010 Jun 29.

PMID:
23199064
[PubMed]
Free PMC Article
20.

Key molecular pathways affected by glaucoma pathology: is predictive diagnosis possible?

Golubnitschaja O, Yeghiazaryan K, Flammer J.

EPMA J. 2010 Jun;1(2):237-44. doi: 10.1007/s13167-010-0031-4. Epub 2010 Jun 29.

PMID:
23199062
[PubMed]
Free PMC Article

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk